Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Mar;87(3):438–443. doi: 10.1111/j.1365-2249.1992.tb03016.x

Antibodies against sulphatide in sera from patients with autoimmune rheumatic diseases.

S Aotsuka 1, M Okawa-Takatsuji 1, S Uwatoko 1, R Yokohari 1, Y Ikeda 1, G Toda 1
PMCID: PMC1554348  PMID: 1544228

Abstract

We tested sera of patients with various autoimmune rheumatic diseases for the presence of antibodies against sulphatide (an acidic glycosphingolipid), identified as a target antigen for antibodies against the liver cell membrane. Thirty-five percent (7/20) of patients with lupus in the active stage possessed anti-sulphatide antibodies, whereas 10% (2/20) of those in the inactive stage and 20% (4/20) of those in the stationary stage possessed such antibodies. Moreover, 10% (3/29) of patients with other autoimmune rheumatic diseases also possessed anti-sulphatide antibodies. The level of anti-sulphatide antibodies was significantly correlated with the levels of anti-double-stranded (ds) DNA antibodies (r = 0.634, P less than 0.001) and dextran sulphate-binding IgG (r = 0.407, P less than 0.001). The serum levels of antibodies against sulphatide were correlated with a history of seizures or psychosis in patients with autoimmune rheumatic diseases. Gels coupled with polyanionic dextran sulphate, monoanionic sulphanilic acid and DNA were shown effectively to adsorb anti-sulphatide antibodies in the sera of patients with active systemic lupus erythematosus (SLE) and autoimmune chronic active hepatitis (AI-CAH). These results suggest that the observed reactivity with sulphatide is due to the presence of antibodies capable of reacting with various anionic molecules in the sera of patients with autoimmune rheumatic diseases as well as those with AI-CAH.

Full text

PDF
438

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel T., Gladman D. D., Urowitz M. B. Neuropsychiatric lupus. J Rheumatol. 1980 May-Jun;7(3):325–333. [PubMed] [Google Scholar]
  2. Aotsuka S., Funahashi T., Tani N., Okawa-Takatsuji M., Kinoshita M., Yokohari R. Adsorption of anti-dsDNA antibodies by immobilized polyanionic compounds. Clin Exp Immunol. 1990 Feb;79(2):215–220. doi: 10.1111/j.1365-2249.1990.tb05181.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aotsuka S., Okawa-Takatsuji M., Kinoshita M., Yokohari R. Analysis of negatively charged dye-binding antibodies reactive with double-stranded DNA and heparan sulfate in serum from patients with rheumatic diseases. Clin Exp Immunol. 1988 Sep;73(3):436–442. [PMC free article] [PubMed] [Google Scholar]
  4. Brinkman K., Termaat R. M., de Jong J., van den Brink H. G., Berden J. H., Smeenk R. J. Cross-reactive binding patterns of monoclonal antibodies to DNA are often caused by DNA/anti-DNA immune complexes. Res Immunol. 1989 Jun-Aug;140(5-6):595–612. doi: 10.1016/0923-2494(89)90122-3. [DOI] [PubMed] [Google Scholar]
  5. Faaber P., Capel P. J., Rijke G. P., Vierwinden G., van de Putte L. B., Koene R. A. Cross-reactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol. 1984 Mar;55(3):502–508. [PMC free article] [PubMed] [Google Scholar]
  6. Faaber P., Rijke T. P., van de Putte L. B., Capel P. J., Berden J. H. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J Clin Invest. 1986 Jun;77(6):1824–1830. doi: 10.1172/JCI112508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lafer E. M., Rauch J., Andrzejewski C., Jr, Mudd D., Furie B., Furie B., Schwartz R. S., Stollar B. D. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med. 1981 Apr 1;153(4):897–909. doi: 10.1084/jem.153.4.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Shoenfeld Y., Rauch J., Massicotte H., Datta S. K., André-Schwartz J., Stollar B. D., Schwartz R. S. Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med. 1983 Feb 24;308(8):414–420. doi: 10.1056/NEJM198302243080802. [DOI] [PubMed] [Google Scholar]
  9. Toda G., Ikeda Y., Hashimoto N., Yamazaki M., Torii M., Oka H. Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases. Clin Exp Immunol. 1983 Dec;54(3):661–670. [PMC free article] [PubMed] [Google Scholar]
  10. Toda G., Ikeda Y., Kashiwagi M., Iwamori M., Oka H. Hepatocyte plasma membrane glycosphingolipid reactive with sera from patients with autoimmune chronic active hepatitis: its identification as sulfatide. Hepatology. 1990 Oct;12(4 Pt 1):664–670. doi: 10.1002/hep.1840120408. [DOI] [PubMed] [Google Scholar]
  11. Vretblad P. Purification of lectins by biospecific affinity chromatography. Biochim Biophys Acta. 1976 May 20;434(1):169–176. doi: 10.1016/0005-2795(76)90047-7. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES